The CER of the CST-Assistant validated for UK regulatory compliance, documenting the product’s clinical performance
Copenhagen, Denmark, 27 August 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · The Clinical Evaluation Report (CER) documents the safety and clinical performance of the CST-Assistant for dementia management · The validation of CER compliance with UK Regulations is an important step towards UK certification of the CST-Assistant as a Medical-Device-Software · Aimee Spector, Professor of Clinical Psychology of Ageing at UCL, UK and the creator of Cognitive Stimulation Therapy (CST), has reviewed the CER and endorsed the clinical relevance of the CST-Assistant · Brain+ is on track